SCHEMBL5899477

SCHEMBL5899477

O=C(CNS(=O)(=O)c1ccc(Br)cc1)c1ccc2ccccc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 4/20 0.65
MMP2 P08253 2/20 0.51
MMP9 P14780 2/20 0.51
MMP1 P03956 1/20 0.51
MMP3 P08254 1/20 0.51
MMP7 P09237 1/20 0.51
MMP13 P45452 1/20 0.51
PTPN1 P18031 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
CTSS P25774 1/20 0.48
CA12 O43570 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
POLB P06746 1/20 0.47
GPR27 Q9NS67 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP19A1 P11511 1/20 0.46
MMP14 P50281 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899462 0.89 KAT6A (0.71) KAT6AMMP1PTPN1MEN1KMT2A
SCHEMBL5899421 0.87 KAT6A (0.65) KAT6AMMP1PTPN1MEN1KMT2A
SCHEMBL5899507 0.85 KAT6A (0.66) KAT6AMMP2MMP1MMP13CA12
SCHEMBL5899737 0.83 MMP1 (0.63) KAT6AMMP2MMP9MMP1MMP3
SCHEMBL5899491 0.82 KAT6A (0.62) KAT6APTPN1CTSSCA12CA1
SCHEMBL5899446 0.79 KAT6A (0.72) KAT6AMEN1KMT2ACTSSPOLB
SCHEMBL19707281 0.78 PTPN1 (0.55) PTPN1MEN1KMT2ACA12CA1
SCHEMBL5899485 0.76 KAT6A (0.63) KAT6APTPN1CA12CA1CA2
SCHEMBL7672302 0.73 GPR27 (0.72) KAT6AMMP2MEN1KMT2AGPR27
SCHEMBL1771503 0.73 CTSS (0.67) KAT6AMMP2MMP9MMP1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KAT6A 2440/4885MMP2 1212/4885MMP9 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.